Boston Scientific Corp. upped the ante for heart devices maker Guidant Corp. again Tuesday, raising its bid to $80 a share, or $27 billion. The new offer from the Natick, Mass.-based company makes its bid worth about $3 billion more than one from Johnson & Johnson, whose rival $24 billion offer the Guidant board accepted last week.
January 18, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Boston Scientific Corp. upped the ante for heart devices maker Guidant Corp. again Tuesday, raising its bid to $80 a share, or $27 billion.
The new offer from the Natick, Mass.-based company makes its bid worth about $3 billion more than one from Johnson & Johnson, whose rival $24 billion offer the Guidant board accepted last week.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
